Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Can We Stop Glacial Melt Before It Triggers a Global Water Crisis? National
  • Shalby Hospitals Surat, One of the Best Multispecialty Hospitals of South Gujarat, Completes 5 Years Business
  • Merit and Nothing but Merit: 500 Scholarships are Announced for Persons with Disabilities by LawSikho Press Release
  • Prepare for the New Normal, says the healthcare industry Business
  • Excelia Business School (France) obtains the renewal of international accreditations EQUIS and AMBA, reaffirming its place amongst the best business schools in the world Education
  • Why Best of Exports Is a Leading Hotel Furniture Manufacturers Company in India Business
  • United Sikhs lauds the recognition of Vaisakhi at the Texas State Capitol Business
  • Into the Wild: Yogesh Bhatia’s Grit and Glory in the Scorching Heat of Indian Jungles Lifestyle

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Medico Remedies Limited to foray into ointment manufacturing segment Business
  • Sarveshwar Foods Reports 36% Jump in Net Profit for H1 FY26 Business
  • Vidyakul students shine at district and state level in UP Board intermediate and high school exams 2023 Business
  • Sharman Joshi and Anees Bazmee launches VisaBoard Revolutionizes Visa Assistance Industry with Cutting-Edge B2B Portal Business
  • Vishal Agarwal takes over as BNI Prometheus President Business
  • YAAP DIGITAL LIMITED IPO Opens on Feb 25, 2026 Business

Recent Posts

  • 12 Exceptional Individuals Making a Difference In 2026
  • Kingston Technology Powers Innvolution Healthcare with Reliable Memory and Storage Solutions
  • Best Crypto Presale in 2026: AlphaPepe Utility Narrative Solidifies Its Lead Over Pepeto and Apeing
  • LANXESS increases sales and earnings in the second quarter of 2026
  • Harini Anand to Represent India at Miss Asia Global 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • ASSOCHAM names Valocity for excellence in innovation & technology at India Fintech Festival Business
  • Reseal presents Maharashtra Udyog Bhushan Puraskar 2024 in Nashik National
  • Meet Rahul Yadav: The Influencer Taking the Online World by Storm Business
  • Indian Food-Tech Startup Easy Cater to Launch Nationwide Hyperlocal Delivery Platform Promising Transparency Business
  • 21st Asian Business & Social Forum 2023 & The Healthier India Conclave 2023 Business
  • YAYAVAR Building India’s Most Successful Licensed Hard Luggage Portfolio Business
  • Something’s Brewing Unveils Bold Expansion Plans: 100 retail footprints by 2025 Business
  • From Consultant to Catalyst: Prashanto Kumar Das and the 5 Pillars of Digital Brand Maturity Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme